PEStore

Venture Capital

The Venture Collective

The Venture Collective backs early-stage and high-growth companies, typically pre-profit, from United States. It states a focus on healthcare & life sciences, software & internet, energy & utilities and industrials & manufacturing.

Disclosed holdings54
Earliest stated investment
HeadquartersUnited States
Largest single fundNot stated

Regulatory record

How The Venture Collective is registered

From this firm's Form ADV, the annual filing every registered and exempt investment adviser makes to the SEC.

Adviser statusExempt reporting adviser
Regulatory assets under managementNot reported by an ERA
Private funds advised35 · $227m gross
SEC adviser numberCRD 313874

An exempt reporting adviser is not required to report regulatory assets under management, so the blank above means the question was not asked rather than that the answer is unknown. Where a figure exists it is the gross asset value of the private funds the firm advises, which is a different and usually larger measure.

Portfolio

Disclosed holdings

Companies The Venture Collective lists on its own website. No investment years are published.

CompanyInvestedYears heldRecorded transaction
Apothékary
Arogga
Axiom Space
BIOS Health
BettaF!sh
Brave Health
Caravel Bio
Cocoon Carbon
Coding Bio
Ellevest
Elysium Health
Entocycle
Epoch Biodesign
Everna
FlyteHealth
Fork & Good
Gravitics
Hale
Helaxy
HelixNano
Laguna Biosciences
Life Biosciences
Liferaft
Lopay
Lyric
Mach
Mimikai
Noda
NovaWurks
Orbem
Orbillion
Pangea Botanica
Phasic Energy
Pragma Biosciences
Qloo
Radian Aerospace
Rebellyous
Red Queen Bio
Rethoric
Ruby Bio
SPARK Neuro
SimpliFed
Snafu Records
Speak
Summer Health
TOKI
Universal Quantum
Unnatural Products
Violet
Wizard
Wonderbelly
X-Energy
Yuri
mDisrupt

Compiled from The Venture Collective’s published portfolio page. Where a recorded transaction is shown, that company was the target of a reported deal and has most likely already been realised. Nothing here is represented as being for sale.

Valuation context

Transaction values in Healthcare & Life Sciences

What companies have actually sold for in healthcare & life sciences, across 1,263 recorded transactions.

Median consideration$110m
Middle 50%$30m-$318m
Revenue multiple2.8×
EBITDA multiple12.5×

The full healthcare & life sciences picture - most active acquirers, recent transactions and every investor in the sector.

For owners

Own a healthcare & life sciences business?

The investors on this page acquire companies like yours. A confidential valuation costs nothing, commits you to nothing, and nobody is told you asked.

Request a confidential valuation

For investors

Is this The Venture Collective?

Claim this profile to correct anything wrong and tell us what you are looking for. We will send matching opportunities as they arise.

Claim or correct this profile

Targeted buyer search

Which hundred of these would actually buy your business?

A researched shortlist with a verified deal-team contact for each, and the reason it is on the list. Fixed fee, from $1,450 - or we make the approach for you and hand you the conversations.

See how it works

Comparable investors

Similar mandates

Other venture capital investors active in healthcare & life sciences.